Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Phillips

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Cell Death and Differentiation|May 23, 2003
A caspase-8-independent component in TRAIL/Apo-2L-induced cell death in human rhabdomyosarcoma cellsI Petak, R Vernes, K S Szucs, et al.
Transplantation Proceedings|April 1, 1990
The effect of donor source on the outcome of living related renal transplantationA O Gaber, I L Jordan, R P Winsett, et al.
Ciba Foundation Symposium|January 1, 1977
Physical and chemical properties of lysozymeC C Blake, D E Grace, L N Johnson, et al.
British Journal of Pharmacology|May 26, 2012
Navitoclax (ABT-263) and bendamustine ± rituximab induce enhanced killing of non-Hodgkin's lymphoma tumours in vivoS Ackler, M J Mitten, J Chen, et al.
Cell Death and Differentiation|October 22, 2011
Genetically defining the mechanism of Puma- and Bim-induced apoptosisS P Garrison, D C Phillips, J R Jeffers, et al.
Biochemistry|February 12, 1985
Lysozyme: a major secretory product of a human colon carcinoma cell lineJ W Fett, D J Strydom, R R Lobb, et al.
Nature|June 19, 1975
Structure of chicken muscle triose phosphate isomerase determined crystallographically at 2.5 angstrom resolution using amino acid sequence dataD W Banner, A C Bloomer, G A Petsko, et al.
Cell Death & Disease|January 16, 2015
Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)J D Leverson, H Zhang, J Chen, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Cell Death and Differentiation|May 23, 2003
A caspase-8-independent component in TRAIL/Apo-2L-induced cell death in human rhabdomyosarcoma cellsI Petak, R Vernes, K S Szucs, et al.
Transplantation Proceedings|April 1, 1990
The effect of donor source on the outcome of living related renal transplantationA O Gaber, I L Jordan, R P Winsett, et al.
Ciba Foundation Symposium|January 1, 1977
Physical and chemical properties of lysozymeC C Blake, D E Grace, L N Johnson, et al.
British Journal of Pharmacology|May 26, 2012
Navitoclax (ABT-263) and bendamustine ± rituximab induce enhanced killing of non-Hodgkin's lymphoma tumours in vivoS Ackler, M J Mitten, J Chen, et al.
Cell Death and Differentiation|October 22, 2011
Genetically defining the mechanism of Puma- and Bim-induced apoptosisS P Garrison, D C Phillips, J R Jeffers, et al.
Biochemistry|February 12, 1985
Lysozyme: a major secretory product of a human colon carcinoma cell lineJ W Fett, D J Strydom, R R Lobb, et al.
Nature|June 19, 1975
Structure of chicken muscle triose phosphate isomerase determined crystallographically at 2.5 angstrom resolution using amino acid sequence dataD W Banner, A C Bloomer, G A Petsko, et al.
Cell Death & Disease|January 16, 2015
Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)J D Leverson, H Zhang, J Chen, et al.
Pageof 7